J&J unit to start mid-stage COVID-19 vaccine trials in Spain

Marco Green
September 14, 2020

Earlier in the day, AstraZeneca resumed clinical trials of its vaccine, developed jointly with the University of Oxford following a brief suspension after one of the participants suffered a side effect last week, causing transverse myelitis, an inflammation of spinal cord.

On the availability of the vaccine and its authorization, Vardhan informed that Centre is considering emergency authorization of COVID-19 vaccination especially in the case of senior citizens and people working in high-risk settings.

On September 6, the drug maker paused the vaccine trials around the world to allow an independent committee and United Kingdom regulators to conduct a review of safety data.

Brazil has the third worst coronavirus outbreak after the United States and India and has become a sought-out testing ground for COVID-19 vaccines under development in Britain, China and Russian Federation. This is the second known hold of studies of the AstraZeneca vaccine.

Twenty-nine vaccines in small-scale safety trials (Phase 1).

Highlighting the importance of the three phases of vaccine trials, the physician said the drug manufacturing company, AstraZeneca, stopped its Oxford University randomised clinical trial when one of the participants developed an unexplained illness.

Joe Biden, the Democratic candidate for president, has accused Trump of "undermining public confidence" by regularly raising the possibility a vaccine will be ready before the election on November 3. Volunteers from some of the worst affected countries - Britain, Brazil, South Africa and the US - are taking part in the trial.

"As our own vaccine candidate under development with Griffith University of Australia will take about 18 months, we are willing to make Covid-19 vaccines for others", says K Anand Kumar, managing director, IIL.

There are 176 coronavirus vaccines in the works.

The offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, England, July 21, 2020.

All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards, AstraZeneca said.

The disease has killed more than 900,000 people worldwide since surfacing in China late previous year, according to an AFP count.

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Other reports by Click Lancashire

Discuss This Article